$0.186
+0.005 (+2.53%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TCRX por análisis de gráficos similares
Alphio's TCRX stock price prediction model matches the current TScan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.19 (+0.25%). The 1-week path is $0.18 (-2.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de TScan Therapeutics Inc?
TScan Therapeutics Inc (TCRX) is not a good buy right now due to its current price of $0.19, which is significantly below its 52-week high of $1.47 and reflects an 81.73% year-to-date decline. The RSI of 43.9 indicates a lack of momentum, and the recent downgrade by analysts to a price target of $1 raises concerns about future profitability and cash runway. The primary risk is the company's negative earnings trend, with a net income loss of $30.4 million reported in Q2 2026, suggesting ongoing financial challenges.
TCRX cerró en $0.19 el Friday, tras subir +2.53%
TScan Therapeutics Inc (TCRX) last closed at $0.1864, gaining +2.53%. These facts feed the 1-day and 1-week TCRX price prediction above.
Factores de la previsión
Los factores de la previsión de TScan Therapeutics Inc (TCRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TCRX, ordenadas por similitud.
Análisis de estacionalidad de TCRX
Historically the probability of a positive November return for TCRX is 4.55%. April offers the highest probability of a positive month at 64.06%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TCRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.76 | $2.10 | $2.47 | +1025.43% |
| Dec 2026 | $1.62 | $2.10 | $2.70 | +1025.43% |
En 2026, se proyecta que TScan Therapeutics Inc (TCRX) oscile entre $1.62 y $2.70.
Previsión mensual de TScan Therapeutics Inc para 2026
En Nov de 2026, se proyecta que TScan Therapeutics Inc promedie $2.10, con un mínimo de $1.76 y un máximo de $2.47.
En Dec de 2026, se proyecta que TScan Therapeutics Inc promedie $2.10, con un mínimo de $1.62 y un máximo de $2.70.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.